Form 4: Cardlytics Chief Legal Officer Granted Significant Equity Awards

Cardlytics, Inc. (CDLX) has granted its Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, 25,000 Restricted Stock Units (RSUs) and 9,375 Performance Stock Units (PSUs) as part of his compensation.

Summary

• Nicholas Hollmeyer Lynton, the Chief Legal & Privacy Officer of Cardlytics, Inc. (CDLX), was granted equity awards on June 23, 2025.
• The grant includes 25,000 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of the Issuer's Common Stock.
• The RSU award vests 50% on June 23, 2026, with the remaining 50% vesting in equal quarterly amounts through June 23, 2027, contingent on continued employment.
• Additionally, 9,375 Performance Stock Units (PSUs) were granted, each representing a contingent right to receive one share of the Issuer's Common Stock.
• The PSU award vests in specified percentages upon the achievement of specified price per share targets, also contingent on continued employment.
• Both RSU and PSU awards were granted at a price of $0, indicating they are compensation grants rather than purchases.

Sentiment

Score: 7

Explanation: The sentiment is positive as it reflects a standard and beneficial practice of executive compensation and retention. It aligns executive interests with shareholder value and incentivizes long-term performance. There are no negative financial implications for the company beyond standard dilution from equity compensation.

Positives

• The grant of 25,000 RSUs and 9,375 PSUs aligns the Chief Legal & Privacy Officer's interests with shareholder value creation.
• Equity awards serve as a strong retention mechanism, incentivizing the executive to remain employed and contribute to the company's long-term success.
• The performance-based vesting of PSUs directly ties a portion of the executive's compensation to the achievement of specific share price targets, potentially driving stock performance.

Negatives

• The vesting of both RSU and PSU awards is contingent on the Reporting Person remaining employed by the Issuer, meaning the executive would forfeit unvested shares upon departure.
• The PSUs' vesting is dependent on achieving specified price per share targets, which introduces uncertainty regarding the ultimate number of shares the executive will receive.

Risks

• The primary risk for the Reporting Person is forfeiture of unvested RSUs and PSUs if employment with Cardlytics, Inc. ceases before vesting dates.
• For PSUs, there is a risk that the specified price per share targets may not be met, leading to a lower or zero payout for that portion of the award.
• Dilution risk for existing shareholders due to the potential issuance of new shares upon vesting of RSUs and PSUs, although this is a standard aspect of equity compensation plans.

Future Outlook

The future outlook for the Chief Legal & Privacy Officer's equity compensation is tied to the company's performance and his continued employment. RSUs are scheduled to vest in two tranches, with the first 50% vesting on June 23, 2026, and the remainder vesting quarterly through June 23, 2027. PSUs will vest based on the achievement of specific share price targets, providing a performance-driven incentive for future periods.

Industry Context

The grant of Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) is a common practice in the technology and publicly traded company sectors. Such equity compensation is widely used to attract, retain, and incentivize key executives by aligning their financial interests with the long-term performance and shareholder value of the company. This practice is standard across various industries for executive compensation.

Comparison to Industry Standards

• The use of RSUs and PSUs as a component of executive compensation is a standard practice across the technology and financial services industries, including companies comparable to Cardlytics.
• Vesting schedules tied to continued employment and performance targets (like share price) are typical structures for such equity awards, aiming to ensure executive retention and performance alignment.
• While specific grant sizes vary based on executive role, company size, and compensation philosophy, the structure of these awards is consistent with industry benchmarks for executive incentive plans.

Management Changes

Stakeholder Impact

• Shareholders: Potential for minor dilution upon vesting of shares, but also benefit from executive retention and alignment of interests with company performance.
• Employees: No direct impact on general employees, but it highlights the company's executive compensation strategy.
• Executive (Nicholas Hollmeyer Lynton): Significant potential for increased personal wealth tied to company stock performance and continued employment.

Next Steps

• The Reporting Person must remain employed by Cardlytics, Inc. for the RSU and PSU awards to vest.
• Cardlytics, Inc. will need to achieve specified price per share targets for the PSUs to vest.
• The company will issue shares to the Reporting Person upon the successful vesting of RSUs and PSUs on their respective vesting dates.

Key Dates

Recommendation

Keywords

Cardlytics, CDLX, SEC Form 4, Restricted Stock Units, RSU, Performance Stock Units, PSU, Equity Compensation, Insider Grant, Executive Compensation, Stock Award, Vesting Schedule